Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.26
(0.23%)
USD 26.26
(0.23%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -24.41 Million USD | -73.3% |
| 2022 | -14.08 Million USD | 21.77% |
| 2021 | -18 Million USD | -436.4% |
| 2020 | -3.35 Million USD | -2098.21% |
| 2019 | 168 Thousand USD | -98.85% |
| 2018 | 14.62 Million USD | 222.03% |
| 2017 | -11.98 Million USD | 37.21% |
| 2016 | -19.08 Million USD | -20.05% |
| 2015 | -15.89 Million USD | -57.14% |
| 2014 | -10.11 Million USD | -32.38% |
| 2013 | -7.64 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -13.56 Million USD | -48.28% |
| 2024 Q2 | -6.47 Million USD | 52.28% |
| 2023 Q2 | -4.22 Million USD | 36.34% |
| 2023 Q3 | -4.39 Million USD | -3.83% |
| 2023 FY | -24.41 Million USD | -73.3% |
| 2023 Q4 | -9.14 Million USD | -108.34% |
| 2023 Q1 | -6.64 Million USD | -729.67% |
| 2022 Q3 | -6.46 Million USD | -3.61% |
| 2022 Q1 | -2.43 Million USD | 67.13% |
| 2022 Q4 | 1.05 Million USD | 116.32% |
| 2022 FY | -14.08 Million USD | 21.77% |
| 2022 Q2 | -6.23 Million USD | -155.91% |
| 2021 Q4 | -7.41 Million USD | 10.93% |
| 2021 Q2 | -2.47 Million USD | -1241.94% |
| 2021 FY | -18 Million USD | -436.4% |
| 2021 Q1 | 217 Thousand USD | -81.11% |
| 2021 Q3 | -8.32 Million USD | -236.08% |
| 2020 Q2 | -237 Thousand USD | 98.16% |
| 2020 Q4 | 1.14 Million USD | -86.7% |
| 2020 FY | -3.35 Million USD | -2098.21% |
| 2020 Q1 | -12.9 Million USD | -585.77% |
| 2020 Q3 | 8.63 Million USD | 3744.73% |
| 2019 Q3 | -11.46 Million USD | -382.3% |
| 2019 Q4 | 2.65 Million USD | 123.17% |
| 2019 Q1 | 11.35 Million USD | -37.35% |
| 2019 Q2 | -2.37 Million USD | -120.94% |
| 2019 FY | 168 Thousand USD | -98.85% |
| 2018 Q1 | -3.51 Million USD | -26.78% |
| 2018 Q4 | 18.13 Million USD | 821.16% |
| 2018 FY | 14.62 Million USD | 222.03% |
| 2018 Q2 | 2.52 Million USD | 171.79% |
| 2018 Q3 | -2.51 Million USD | -199.68% |
| 2017 Q3 | -5.69 Million USD | -483.56% |
| 2017 Q2 | 1.48 Million USD | 129.64% |
| 2017 Q1 | -5 Million USD | 17.96% |
| 2017 FY | -11.98 Million USD | 37.21% |
| 2017 Q4 | -2.77 Million USD | 51.32% |
| 2016 Q2 | -4.63 Million USD | -3.18% |
| 2016 FY | -19.08 Million USD | -20.05% |
| 2016 Q1 | -4.49 Million USD | 12.26% |
| 2016 Q4 | -6.1 Million USD | -58.49% |
| 2016 Q3 | -3.85 Million USD | 17.01% |
| 2015 Q2 | -3.73 Million USD | -20.59% |
| 2015 Q1 | -3.09 Million USD | -12.68% |
| 2015 Q4 | -5.12 Million USD | -29.66% |
| 2015 FY | -15.89 Million USD | -57.14% |
| 2015 Q3 | -3.95 Million USD | -5.95% |
| 2014 Q4 | -2.74 Million USD | -11.95% |
| 2014 Q1 | -2.32 Million USD | -23.53% |
| 2014 FY | -10.11 Million USD | -32.38% |
| 2014 Q2 | -2.59 Million USD | -11.66% |
| 2014 Q3 | -2.45 Million USD | 5.55% |
| 2013 Q3 | -2.07 Million USD | 6.34% |
| 2013 Q1 | -1.46 Million USD | 0.0% |
| 2013 Q2 | -2.21 Million USD | -51.35% |
| 2013 Q4 | -1.88 Million USD | 9.4% |
| 2013 FY | -7.64 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -19.93 Million USD | -22.452% |
| BIMI International Medical Inc. | -22.35 Million USD | -9.208% |
| China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -476.516% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | -0.0% |
| Leafly Holdings, Inc. | -9.49 Million USD | -157.012% |
| Leafly Holdings, Inc. | -9.49 Million USD | -157.012% |
| LifeMD, Inc. | -20.59 Million USD | -18.523% |
| LifeMD, Inc. | -20.59 Million USD | -18.523% |
| TRxADE HEALTH, Inc. | -17.84 Million USD | -36.806% |
| PetMed Express, Inc. | -7.46 Million USD | -227.05% |
| Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.717% |